Wistar scientists develop novel antibody treatment for kidney cancer
PHILADELPHIA — (June 04, 2024) — Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 patients ultimately survive. Credit: The Wistar Institute PHILADELPHIA — (June 04, 2024)